Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma.

Prognostic factors for disease progression after high-dose chemotherapy and autologous hematopoietic stem cell transplantation for recurrent or refractory Hodgkin's lymphoma. Bone Marrow Transplant. 2004 May; 33(10):1015-23.

View in: PubMed

subject areas

Acute Disease
Adult
Disease Progression
Disease-Free Survival
Female
Graft vs Host Disease
Hematopoietic Stem Cell Transplantation
Hodgkin Disease
Humans
Male
Middle Aged
Multivariate Analysis
Prognosis
Recurrence
Risk Factors
Time Factors
Transplantation, Homologous
Treatment Outcome

authors with profiles

Koen Van Besien